• Journal Article

Lipid-based carriers for pulmonary products: Preclinical development and case studies in humans

Citation

Cipolla, D., Shekunov, B., Blanchard, J., & Hickey, A. (2014). Lipid-based carriers for pulmonary products: Preclinical development and case studies in humans. Advanced Drug Delivery Reviews, 75, 53-80. DOI: 10.1016/j.addr.2014.05.001

Abstract

A number of lipid-based technologies have been applied to pharmaceuticals to modify their drug release characteristics, and additionally, to improve the drug loading for poorly soluble drugs. These technologies, including solid-state lipid microparticles, many of which are porous in nature, liposomes, solid lipid nanoparticles and nanostructured lipid carriers, are increasingly being developed for inhalation applications. This article provides a review of the rationale for the use of these technologies in the pulmonary delivery of drugs, and summarizes the manufacturing processes and their limitations, the in vitro and in vivo performance of these systems, the safety of these lipid-based systems in the lung, and their promise for commercialization